Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 104.10
-0.60 (-0.57%)
Jul 23, 2026, 3:17 PM AST
Dallah Healthcare Company Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,247 | 4,067 | 3,206 | 2,943 | 2,488 | 2,105 |
Revenue Growth | 30.51% | 26.86% | 8.93% | 18.28% | 18.18% | 59.69% |
Gross Profit Gross Profit Growth | 1,426 | 1,389 | 1,133 | 1,021 | 857.34 | 744.2 |
Operating Income Operating Income Growth | 588.27 | 594.4 | 567.16 | 506.4 | 418.29 | 361.38 |
Net Income Net Income Growth | 467.23 | 538.27 | 471.2 | 360.12 | 274.46 | 258.6 |
Earnings Per Share EPS Growth | 4.58 | 5.32 | 4.83 | 3.70 | 3.05 | 2.87 |
EPS Growth | -12.00% | 10.12% | 30.59% | 21.31% | 6.13% | 87.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Distribution of Pharmaceutical Products Distribution of Pharmaceutical Products Growth | 149.25 | 151.58 | 151.94 | 133.4 | 120.08 | 138.29 |
Medical Facilities and Pharmacies Medical Facilities and Pharmacies Growth | 4,098 | 3,915 | 3,054 | 2,809 | 2,368 | 1,967 |
Total Total Growth | 4,247 | 4,067 | 3,206 | 2,943 | 2,488 | 2,105 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 187.42 | 210.57 | 166.32 | 235.31 | 237.94 | 208.08 |
Total Debt Total Debt Growth | 4,018 | 3,934 | 2,023 | 1,973 | 1,977 | 1,889 |
Net Cash (Debt) Net Cash Growth | -3,831 | -3,723 | -1,857 | -1,738 | -1,740 | -1,681 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -37.54 | -36.80 | -19.04 | -17.85 | -19.33 | -18.68 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 383.89 | 555.39 | 678.29 | 625.78 | 442.13 | 361.55 |
Capital Expenditures CapEx Growth | -448.18 | -465.29 | -363.64 | -294.51 | -172.69 | -115.62 |
Free Cash Flow Free Cash Flow Growth | -64.28 | 90.1 | 314.65 | 331.28 | 269.44 | 245.93 |
Free Cash Flow Growth | - | -71.36% | -5.02% | 22.95% | 9.56% | 356.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.56% | 34.16% | 35.33% | 34.71% | 34.46% | 35.35% |
Operating Margin | 13.85% | 14.62% | 17.69% | 17.21% | 16.81% | 17.17% |
Pretax Margin | 11.22% | 13.51% | 15.70% | 13.60% | 13.23% | 13.86% |
Profit Margin | 11.00% | 13.23% | 14.70% | 12.24% | 11.03% | 12.28% |
FCF Margin | -1.51% | 2.22% | 9.81% | 11.26% | 10.83% | 11.68% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 2.000 | 1.500 | 2.500 | 1.500 |
Dividend Per Share Growth | -20.00% | 0% | 33.33% | -40.00% | 66.67% | 100.00% |
Dividend Yield | 1.92% | 1.61% | 1.37% | 0.91% | 1.77% | 2.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.74 | 23.60 | 31.00 | 46.60 | 48.53 | 26.14 |
Forward PE | 20.26 | 21.66 | 28.71 | 41.05 | 42.65 | 32.23 |
P/FCF Ratio | - | 140.95 | 46.43 | 50.66 | 49.44 | 27.48 |
PS Ratio | 2.47 | 3.12 | 4.56 | 5.70 | 5.35 | 3.21 |